References
- Cartwright R A, Watkins G. Epidemiology of Hodgkin's disease: a review. Hematol Oncol 2004; 22: 11–26
- Razis D V, Diamond H D, Craver L F. Familial Hodgkin's disease: its significance and implications. Ann Intern Med 1959; 51: 933–971
- Goldin L R, Pfeiffer R M, Gridley G, Gail M H, Li X, Mellemkjaer L, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004; 100: 1902–1908
- Altieri A, Hemminki K. The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database. Leukemia 2006; 20: 2062–2063
- Mack T M, Cozen W, Shibata D K, Weiss L M, Nathwani B N, Hernandez A M, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 332: 413–418
- Rehman J U, Burney I A, Al Kindi S, Raeburn S. Familial lymphoma in an Omani kindred with identical class II HLA type. Leuk Lymphoma 2008; 49: 1407–1410
- Bauduer F, Vassallo J, Delsol G, Brousset P. Clustering and anticipation for nodular lymphocyte predominance Hodgkin lymphoma within a French Basque kindred. Br J Haematol 2005; 130: 649
- Campbell G N, Lloyd J, Wotherspoon A, Coulter C, Bain B J. Nodular lymphocyte predominant Hodgkin lymphoma in siblings. Leuk Lymphoma 2004; 45: 609–611
- Unal A, Sari I, Deniz K, Ozkan M, Kontas O, Eser B, et al. Familial nodular lymphocyte predominant Hodgkin lymphoma: successful treatment with CHOP plus rituximab. Leuk Lymphoma 2005; 46: 1613–1617
- Harty L C, Lin A Y, Goldstein A M, Jaffe E S, Carrington M, Tucker M A, et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood 2002; 99: 690–693
- McAulay K A, Higgins C D, Macseen K F, Lake A, Jarrett R J, Robertson F L, et al. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007; 117: 3042–3048
- Niens M, Jarrett R F, Hepkema B, Nolte I M, Diepstra A, Platteel M, et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV + Hodgkin lymphoma. Blood 2007; 110: 3310–3315
- Goldin L R, McMaster M L, Ter-Minassian M, Saddlemire S, Harmsen B, Lalonde G, et al. A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. J Med Genet 2005; 42: 595–601
- de Silva G N, Bacchi M M, Rainho C A, de Oliveira D E. Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma. Arch Pathol Lab Med 2007; 131: 1691–1696